Application for Reimbursement for Specialty care high-cost medicine (SCHCM) – Biosimilar or Generic drugs

The Icelandic Medicines Agency determines whether reimbursement is approved for Specialty Care High-cost Medicines, based on an opinion from the Landspítali Hospital Drug Committee.

Regulation No. 1414/2020

Cost

No cost